{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:35:17Z","timestamp":1792719317537,"version":"4.5.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,19]]},"DOI":"10.1097\/qad.0b013e32834785cf","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T03:10:01Z","timestamp":1303269001000},"page":"1247-1257","source":"Crossref","is-referenced-by-count":20,"title":["Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies"],"prefix":"10.1097","volume":"25","author":[{"given":"Harvir","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampson ST","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Chruscinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210130","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nm.1974","article-title":"Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques","volume":"15","author":"Hessell","year":"2009","journal-title":"Nat Med"},{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/JVI.01272-09","article-title":"Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L","volume":"84","author":"Hessell","year":"2010","journal-title":"J Virol"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1128\/JVI.73.5.4009-4018.1999","article-title":"Protection of Macaques against pathogenic simian\/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies","volume":"73","author":"Mascola","year":"1999","journal-title":"J Virol"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/72318","article-title":"Protection of macaques against vaginal transmission of a pathogenic HIV-1\/SIV chimeric virus by passive infusion of neutralizing antibodies","volume":"6","author":"Mascola","year":"2000","journal-title":"Nat Med"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"e16857","DOI":"10.1371\/journal.pone.0016857","article-title":"Comparison of antibody repertoires produced by HIV-1 Infection, other chronic and acute infections, and systemic autoimmune disease.","volume":"6","author":"Breden","year":"2011","journal-title":"PLoS One"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/MMBR.00020-07","article-title":"The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design","volume":"72","author":"Montero","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"key":"R7-1-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2004.12.011","article-title":"Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41","volume":"22","author":"Cardoso","year":"2005","journal-title":"Immunity"},{"key":"R8-1-20210130","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1128\/JVI.78.19.10724-10737.2004","article-title":"Structure and mechanistic analysis of the antihuman immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope","volume":"78","author":"Ofek","year":"2004","journal-title":"J Virol"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"20234","DOI":"10.1073\/pnas.0908713106","article-title":"Role of HIV membrane in neutralization by two broadly neutralizing antibodies","volume":"106","author":"Alam","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-1-20210130","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1128\/JVI.02357-09","article-title":"Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding","volume":"84","author":"Julien","year":"2010","journal-title":"J Virol"},{"key":"R11-1-20210130","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1128\/JVI.02257-09","article-title":"Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region","volume":"84","author":"Ofek","year":"2010","journal-title":"J Virol"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/JVI.02113-09","article-title":"Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity","volume":"84","author":"Xu","year":"2010","journal-title":"J Virol"},{"key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.78.6.3155-3161.2004","article-title":"The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing antihuman immunodeficiency virus type 1 antibody 2F5","volume":"78","author":"Zwick","year":"2004","journal-title":"J Virol"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/science.1111781","article-title":"Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies","volume":"308","author":"Haynes","year":"2005","journal-title":"Science"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.4049\/jimmunol.178.7.4424","article-title":"The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes","volume":"178","author":"Alam","year":"2007","journal-title":"J Immunol"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbrc.2007.01.033","article-title":"Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate","volume":"354","author":"Beck","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbamem.2008.11.015","article-title":"Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1","volume":"1788","author":"Matyas","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/QAD.0b013e32832faea5","article-title":"Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes","volume":"23","author":"Matyas","year":"2009","journal-title":"AIDS"},{"key":"R19-1-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/HAB-2005-143-402","article-title":"Antibody polyspecificity and neutralization of HIV-1: a hypothesis","volume":"14","author":"Haynes","year":"2005","journal-title":"Hum Antibodies"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1126\/science.1114854","article-title":"Immunology. Close to the edge: neutralizing the HIV-1 envelope","volume":"308","author":"Nabel","year":"2005","journal-title":"Science"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/QAD.0b013e328285da15","article-title":"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data","volume":"21","author":"Vcelar","year":"2007","journal-title":"AIDS"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1073\/pnas.0912914107","article-title":"Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance","volume":"107","author":"Verkoczy","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"9570","DOI":"10.1021\/bi010640u","article-title":"The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well defined helix in dodecylphosphocholine micelles","volume":"40","author":"Schibli","year":"2001","journal-title":"Biochemistry"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.immuni.2007.11.018","article-title":"HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane","volume":"28","author":"Sun","year":"2008","journal-title":"Immunity"},{"key":"R26-1-20210130","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0901474106","article-title":"Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface","volume":"106","author":"Song","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-1-20210130","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1128\/JVI.00571-09","article-title":"Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions","volume":"83","author":"Dennison","year":"2009","journal-title":"J Virol"},{"key":"R28-1-20210130","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/v1030802","article-title":"Maturation pathways of cross-reactive HIV-1 neutralizing antibodies","volume":"1","author":"Xiao","year":"2009","journal-title":"Viruses"},{"key":"R29-1-20210130","doi-asserted-by":"crossref","first-page":"8925","DOI":"10.1128\/JVI.00758-09","article-title":"Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors","volume":"83","author":"Gray","year":"2009","journal-title":"J Virol"},{"key":"R30-1-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/jaut.1999.0324","article-title":"Antiphospholipid antibodies in HIV infection and SLE with or without antiphospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI","volume":"13","author":"Petrovas","year":"1999","journal-title":"J Autoimmun"},{"key":"R31-1-20210130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1055\/s-0038-1656067","article-title":"Autoantibodies to phospholipids and to the coagulation proteins in AIDS","volume":"77","author":"Abuaf","year":"1997","journal-title":"Thromb Haemost"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/ard.62.11.1106","article-title":"Anticardiolipin, antibeta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease","volume":"62","author":"Loizou","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R33-1-20210130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm1244","article-title":"Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies","volume":"11","author":"Trkola","year":"2005","journal-title":"Nat Med"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2009.12.059","article-title":"Engineering filamentous phage carriers to improve focusing of antibody responses against peptides","volume":"28","author":"van Houten","year":"2010","journal-title":"Vaccine"},{"key":"R36-1-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2141.1999.01292.x","article-title":"Characterization of IgG monoclonal anticardiolipin\/antibeta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies","volume":"105","author":"Zhu","year":"1999","journal-title":"Br J Haematol"},{"key":"R37-1-20210130","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/QAD.0b013e3282a4a632","article-title":"Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity","volume":"21","author":"Scherer","year":"2007","journal-title":"AIDS"},{"key":"R39-1-20210130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jmb.2004.02.051","article-title":"Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope","volume":"338","author":"Menendez","year":"2004","journal-title":"J Mol Biol"},{"key":"R40-1-20210130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/art.10836","article-title":"Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome","volume":"48","author":"Visvanathan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R41-1-20210130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nm0302-295","article-title":"Autoantigen microarrays for multiplex characterization of autoantibody responses","volume":"8","author":"Robinson","year":"2002","journal-title":"Nat Med"},{"key":"R42-1-20210130","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1073\/pnas.93.16.8606","article-title":"A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice","volume":"93","author":"Olee","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.21370","article-title":"Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis","volume":"63","author":"Garren","year":"2008","journal-title":"Ann Neurol"},{"key":"R44-1-20210130","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.21269","article-title":"Antigen microarray profiling of autoantibodies in rheumatoid arthritis","volume":"52","author":"Hueber","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4049\/jimmunol.0901748","article-title":"IFN regulatory factor 5 is required for disease development in the FcgammaRIIB\u2212\/\u2212Yaa and FcgammaRIIB\u2212\/\u2212 mouse models of systemic lupus erythematosus","volume":"184","author":"Richez","year":"2010","journal-title":"J Immunol"},{"key":"R46-1-20210130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nbt859","article-title":"Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis","volume":"21","author":"Robinson","year":"2003","journal-title":"Nat Biotechnol"},{"key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.4049\/jimmunol.177.10.7423","article-title":"Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus","volume":"177","author":"Sekine","year":"2006","journal-title":"J Immunol"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI30065","article-title":"IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice","volume":"118","author":"Thibault","year":"2008","journal-title":"J Clin Invest"},{"key":"R49-1-20210130","doi-asserted-by":"crossref","first-page":"R112","DOI":"10.1186\/ar2771","article-title":"Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus","volume":"11","author":"Thibault","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"R51-1-20210130","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/JVI.80.4.1680-1687.2006","article-title":"Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody","volume":"80","author":"Brunel","year":"2006","journal-title":"J Virol"},{"key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R53-1-20210130","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54-1-20210130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2007.01.009","article-title":"Autoreactivity in human IgG+ memory B cells","volume":"26","author":"Tiller","year":"2007","journal-title":"Immunity"},{"key":"R55-1-20210130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature09385","article-title":"Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation","volume":"467","author":"Mouquet","year":"2010","journal-title":"Nature"},{"key":"R56-1-20210130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J Immunol Methods"},{"key":"R57-1-20210130","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1084\/jem.20092712","article-title":"Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity","volume":"207","author":"Guo","year":"2010","journal-title":"J Exp Med"},{"key":"R58-1-20210130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/intimm\/dxh323","article-title":"An antibody VH gene that promotes marginal zone B cell development and heavy chain allelic exclusion","volume":"17","author":"Heltemes-Harris","year":"2005","journal-title":"Int Immunol"},{"key":"R59-1-20210130","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1128\/JVI.01482-09","article-title":"Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables","volume":"84","author":"Doria-Rose","year":"2010","journal-title":"J Virol"},{"key":"R60-1-20210130","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1128\/JVI.01149-09","article-title":"Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression","volume":"83","author":"Piantadosi","year":"2009","journal-title":"J Virol"},{"key":"R61-1-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1783","article-title":"Antiviral antibody responses: the two extremes of a wide spectrum","volume":"6","author":"Hangartner","year":"2006","journal-title":"Nat Rev Immunol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201106190-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:24:33Z","timestamp":1786044273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201106190-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,19]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32834785cf","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,19]]}}}